T1	Participants 29 81	advanced Hodgkin's disease: a report on 218 patients
T2	Participants 276 407	patients with advanced stage Hodgkin's disease (HD), as well as in early stage patients with systemic symptoms and/or bulky disease
T3	Participants 428 469	218 patients with previously untreated HD
